Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer.

导出原文传递

翻译打印收藏纠错

作者： Lobna,Ouldamer ^[1] ; Marie,Chas ^[2] ; Flavie,Arbion ^[3] ; Gilles,Body ^[4] ; Julien,Cirier ^[4] ; Marcos,Ballester ^[5] ; Sofiane,Bendifallah ^[6] ; Emile,Daraï ^[5]

作者单位： Department of Gynecology, Centre Hospitalier Universitaire de Tours, Tours, France; INSERM U1069, Université François-Rabelais, Tours, France. Electronic address: l.ouldamer@chu-tours.fr. ^[1] Department of Gynecology, Centre Hospitalier Universitaire de Tours, Tours, France. ^[2] INSERM U1069, Université François-Rabelais, Tours, France; Department of Pathology, Centre Hospitalier Universitaire de Tours, Tours, France. ^[3] Department of Gynecology, Centre Hospitalier Universitaire de Tours, Tours, France; INSERM U1069, Université François-Rabelais, Tours, France. ^[4] Department of Obstetrics and Gynaecology, Hôpital Tenon, Paris, France; INSERM UMR S 938, Université Pierre et Marie Curie, Paris, France. ^[5] Department of Obstetrics and Gynaecology, Hôpital Tenon, Paris, France; UMR S 707, Epidemiology, Information Systems, Modeling, Université Pierre et Marie Curie, Paris, France. ^[6]

关键词 Axillary response Breast cancer Neoadjuvant chemotherapy Risk scoring system